These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6698047)

  • 21. Plasma and cyst fluid levels of delta 5 and delta 4 steroid hormones in women with gross cystic breast disease.
    Inaudi P; Bernabei A; Gioffré W; Franchi F; Mazzullo G; De Leo V; D'Antona N
    Clin Endocrinol (Oxf); 1987 Dec; 27(6):643-8. PubMed ID: 2970900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal profiles in lactating and non-lactating women immediately after delivery and their relationship to breast engorgement.
    West CP; McNeilly AS
    Br J Obstet Gynaecol; 1979 Jul; 86(7):501-6. PubMed ID: 476015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid hormones in benign breast disease. Normalization of exaggerated prolactin responsiveness to thyrotropin-releasing hormone.
    Peters F; Pickardt CR; Breckwoldt M
    Cancer; 1985 Sep; 56(5):1082-5. PubMed ID: 3926294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum prolactin levels in women with gross cystic breast disease.
    Vizoso F; Allende MT; García-Muñiz JL; Alexandre E; Fueyo A; Ruibal A
    Int J Biol Markers; 1992; 7(4):225-9. PubMed ID: 1491178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Endocrine markers in benign breast diseases].
    Thalabard JC; Sitruk-Ware R; Kuttenn F; Mauvais-Jarvis P
    Zentralbl Gynakol; 1986; 108(6):354-8. PubMed ID: 3716674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrocystic disease of the breast.
    Greenblatt RB; Samaras C; Vasquez JM; Nezhat C
    Clin Obstet Gynecol; 1982 Jun; 25(2):365-71. PubMed ID: 7105513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast].
    Sieja K; Stanosz S
    Ginekol Pol; 2002 Jul; 73(7):594-9. PubMed ID: 12375569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Danazol treatment of chronic cystic mastopathy: a clinical and hormonal evaluation.
    Dhont M; Delbeke L; van Eyck J; Voorhoof L
    Postgrad Med J; 1979; 55 Suppl 5():66-70. PubMed ID: 395523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of benign breast disease with bromocriptine.
    Mussa A; Dogliotti L
    J Endocrinol Invest; 1979; 2(1):87-91. PubMed ID: 489922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles].
    Kubista E; Müller G; Spona J
    Rev Fr Gynecol Obstet; 1987 Apr; 82(4):221-7. PubMed ID: 3589362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex steroid hormones in serum and tissue of benign and malignant breast tumor patients.
    Mady EA; Ramadan EE; Ossman AA
    Dis Markers; 2000; 16(3-4):151-7. PubMed ID: 11381198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization.
    Wu E; Xiao B; Yan W; Li H; Wu B
    Contraception; 1992 Jun; 45(6):583-93. PubMed ID: 1617967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N; Bove F; Gentile A; Parmeggiani U
    Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF and endocrine studies of premenstrual syndrome.
    Parry BL; Gerner RH; Wilkins JN; Halaris AE; Carlson HE; Hershman JM; Linnoila M; Merrill J; Gold PW; Gracely R
    Neuropsychopharmacology; 1991 Sep; 5(2):127-37. PubMed ID: 1930615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women.
    Meyer F; Brown JB; Morrison AS; MacMahon B
    J Natl Cancer Inst; 1986 Sep; 77(3):613-6. PubMed ID: 3462404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteal phase hyperprolactinemia.
    Falk RJ; Anderson L
    Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum prolactin levels in patients with fibrocystic breast disease.
    Peters F; Schuth W; Scheurich B; Breckwoldt M
    Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of plasma prolactin in patients with breast dysplasia].
    Vázquez Albaladejo C; Ferrer S; Merle S; Sanchis V; Camps Roig J; Giménez Climent J
    Rev Esp Oncol; 1983; 30(3):323-36. PubMed ID: 6571376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.